Page last updated: 2024-11-05

reproterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

reproterol: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25654
CHEMBL ID1095607
CHEBI ID135612
SCHEMBL ID83298
MeSH IDM0063597

Synonyms (34)

Synonym
7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione
54063-54-6
reproterol
einecs 258-956-1
7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)theophylline
reproterolum [inn-latin]
brn 0590567
theophylline, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-
7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)theophylline
1,2,3,6-tetrahydro-1,3-dimethyl-7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)-2,6-purindion
reproterol [inn:ban]
d 1959
L013423
CHEBI:135612
reproterol (inn)
D08474
CHEMBL1095607
d-1959
7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-1,3-dimethylpurine-2,6-dione
reproterolum
unii-11941yc6rn
5-26-14-00026 (beilstein handbook reference)
11941yc6rn ,
SCHEMBL83298
7-(3-((.beta.,3,5-trihydroxyphenethyl)amino)propyl)theophylline
reproterol [inn]
reproterol [mi]
reproterol [who-dd]
1h-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-
DTXSID8023553
DB12846
Q1292703
HY-135490
CS-0113240

Research Excerpts

Overview

Reproterol is a monomolecular combination of orciprenaline and theophylline. Used as beta-adrenergic agonist to induce bronchodilation in bronchial asthma.

ExcerptReferenceRelevance
"Reproterol is a monomulecolar combination of catecholamine and theophilline."( [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
Bonaduce, D; Canonico, V; Cocozza, M; Ferrara, N; Petretta, M; Rengo, F; Romano, E, 1981
)
1.28
"Reproterol is a monomolecular combination of orciprenaline and theophylline used as beta-adrenergic agonist to induce bronchodilation in bronchial asthma. "( Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
Juergens, UR; Stöber, M; Vetter, H, 1999
)
3.19
"Reproterol is a synthetic selective beta-adrenoceptor agonist with a xanthine side chain. "( Bronchial and cardiovascular responses to inhaled reproterol in asthmatics: a double-blind placebo controlled dose-response study.
Burge, PS; Patchett, P; Patchett, SM, 1985
)
1.97

Compound-Compound Interactions

The therapeutic value of 80 micrograms atropine methonitrate delivered per metered aerosol was investigated in a controlled double-blind cross-over trial in 17 patients with chronic bronchitis.

ExcerptReferenceRelevance
"The therapeutic value of 80 micrograms atropine methonitrate delivered per metered aerosol and its combination with 450 micrograms reproterol was investigated in a controlled double-blind cross-over trial in 17 patients with chronic bronchitis and airway obstruction."( Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
Aurich, R; Macha, HN, 1982
)
0.7
" Therefore, we studied the effect of the beta2-agonist reproterol in combination with DSCG."( Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholine.
Jörres, RA; Kanniess, F; Magnussen, H, 2005
)
0.98

Dosage Studied

The metaphenolic bronchodilators reproterol, salbutamol, fenoterol, and terbutaline were introduced at a dosage of 0.5 mg each. We determined the inhaled adenosine dose-response curves after no treatment and after treatment with aminophylline (240 mg in 10 min) and reproerol (90 mcg in 2 min)

ExcerptRelevanceReference
" We determined the inhaled adenosine dose-response curves after no treatment and after treatment with aminophylline (240 mg in 10 min), reproterol (90 mcg in 2 min) and salbutamol (100 mcg in 2 min) administered intravenously 15 min before adenosine and reproterol (500 mcg) and salbutamol (200 mcg) administered by inhalation from a metered aerosol 30 min before adenosine on separate days."( Role of purinergic system in tracheobronchial reactivity of healthy and bronchopathic subjects.
Carapella, N; Filippelli, A; Loffreda, A; Marmo, E; Matera, MG; Montanaro, C; Santagata, A; Servodio, R; Susanna, V, 1990
)
0.48
" It was also found in the bile of orally or intravenously dosed rats in the form of glucuronides."( Biotransformation of reproterol in the intestinal tract of the rat.
Kucharczyk, N; Sofia, RD; Yang, JT, 1981
)
0.58
" Twenty-four young male and female healthy subjects were randomly allocated in gender-balanced fashion to 4 parallel treatment groups with single and repeated dosing of either reproterol + DSCG by HFA- or CFC-MDI (each time N = 8) or placebo by HFA- or CFC-MDI (each time N = 4) using matched placebo devices thus allowing a double-blind (with regard to placebo) approach."( Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
de Mey, C; Hermann, R; Ruus, P; Schneider, E, 1998
)
0.7
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oxopurine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID567091Drug absorption in human assessed as human intestinal absorption rate2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
AID476929Human intestinal absorption in po dosed human2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-199033 (52.38)18.7374
1990's16 (25.40)18.2507
2000's11 (17.46)29.6817
2010's3 (4.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.65 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index76.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials22 (32.84%)5.53%
Reviews1 (1.49%)6.00%
Case Studies1 (1.49%)4.05%
Observational0 (0.00%)0.25%
Other43 (64.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Trial to Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol in Comparison to the Single Components and Placebo in Adults With Exercise Induced Asthma Randomised, Placebo-controlled, Double-blind, C [NCT00777348]Phase 262 participants (Actual)Interventional2007-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]